Table 2.
Baseline characteristics of 1096 subjects, stratified by quartiles of fibrinogen.
| Characteristics | Quartiles of fibrinogen (g/L) | P value | |||
|---|---|---|---|---|---|
| Q1 (≤3.01) N = 276 |
Q2 (3.02-3.65) N = 274 |
Q3 (3.66-4.55) N = 274 |
Q4 (≥4.56) N = 272 |
||
| PAD no. (%) | 188 (68.1%) | 224 (81.8%) | 234 (85.4%) | 241 (88.6%) | <0.001 |
| Male no. (%) | 125 (45.3%) | 125 (45.6%) | 112 (40.9%) | 112 (41.2%) | 0.533 |
| Age | 63.60 ± 10.79 | 62.81 ± 11.44 | 62.80 ± 11.17 | 63.70 ± 11.46 | 0.668 |
| Smoking (%) | 89 (32.2%) | 72 (26.3%) | 101 (36.9%) | 87 (32%) | 0.068 |
| Alcohol use (%) | 67 (24.3%) | 57 (20.8%) | 60 (21.9%) | 67 (24.6%) | 0.661 |
| Diabetes duration (months) | 117.64 ± 85.96 | 107.87 ± 74.67 | 113.32 ± 87.46 | 112.98 ± 81.46 | 0.587 |
| Stroke (%) | 105 (38.0%) | 110 (40.1%) | 107 (39.1%) | 112 (41.2%) | 0.890 |
| Hypertension (%) | 142 (51.4%) | 166 (60.6%) | 194 (70.8%) | 188 (69.1%) | <0.001 |
| Weight (kg) | 64.14 ± 11.22 | 64.63 ± 11.59 | 65.13 ± 11.36 | 64.15 ± 11.15 | 0.700 |
| Height (cm) | 161.53 ± 8.42 | 161.92 ± 8.55 | 162.5 ± 8.76 | 162.14 ± 7.98 | 0.587 |
| BMI (kg/m2) | 24.49 ± 3.32 | 24.51 ± 3.73 | 24.63 ± 3.50 | 24.29 ± 3.34 | 0.711 |
| Waist circumference (cm) | 90.33 ± 10.53 | 90.52 ± 10.93 | 90.63 ± 10.91 | 90.07 ± 10.61 | 0.936 |
| Hip circumference (cm) | 94.93 ± 8.42 | 95.06 ± 8.61 | 95.41 ± 8.58 | 95.06 ± 10.79 | 0.938 |
| Waist/hip ratio | 0.95 ± 0.07 | 0.95 ± 0.07 | 0.95 ± 0.07 | 0.98 ± 0.51 | 0.619 |
| TC (mmol/L) | 4.67 ± 1.15 | 4.74 ± 1.34 | 4.69 ± 1.21 | 4.65 ± 2.54 | 0.926 |
| TG (mmol/L) | 1.82 ± 1.54 | 2.03 ± 1.90 | 1.76 ± 1.11 | 1.63 ± 1.28 | 0.021 |
| HDL-C (mmol/L) | 1.13 ± 0.32 | 1.09 ± 0.32 | 1.10 ± 0.32 | 0.97 ± 0.29 | <0.001 |
| LDL-C (mmol/L) | 2.70 ± 0.87 | 2.70 ± 1.01 | 2.74 ± 0.94 | 2.72 ± 1.19 | 0.975 |
| HbA1c (%) | 9.08 ± 2.17 | 9.14 ± 2.20 | 9.14 ± 2.27 | 9.40 ± 2.24 | 0.340 |
PAD: peripheral arterial disease; BMI: body mass index; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low-density lipoprotein-cholesterol.